PCRX.V PharmaCorp Rx Inc.
- Market cap
- CAD 77.8M
- P/E
- -
- P/B
- 1.51x
- ROE
- 0.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is PCRX.V undervalued?
Graham numberThe Graham number of PharmaCorp Rx Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
PharmaCorp Rx Inc. fundamental analysis
No fundamental analysis for PharmaCorp Rx Inc. yet.
PharmaCorp Rx Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About PharmaCorp Rx Inc.
PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. The company offers prescription services; front-of-store retail, such as convenience goods, over-the-counter medications, health products, and wellness items; custom compounding; specialized consultations; and lifestyle programs. PharmaCorp Rx Inc. was incorporated in 2021 and is headquartered in Saskatoon, Canada.
Full company profilePharmaCorp Rx Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
PharmaCorp Rx Inc. annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0.00 | 0.00 | 5.79M | 20.9M | 29.8M |
| Gross Profit | - | 0.00 | 2.18M | 8.30M | 11.8M |
| Operating Income | -563K | -578K | -1.59M | -1.24M | -342K |
| EBITDA | -563K | -470K | -835K | 204K | 1.99M |
| Net Income | -517K | -470K | -1.05M | -1.42M | 277K |
| EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Balance Sheet | |||||
| Total Assets | 2.73M | 2.32M | 35.2M | 65.6M | 64.3M |
| Total Liabilities | 16.5K | 46.2K | 4.64M | 13.3M | 11.2M |
| Shareholders' Equity | 2.72M | 2.27M | 30.3M | 51.9M | 52.8M |
| Cash & Short-term Investments | 2.73M | 2.24M | 12.9M | 25.9M | 24.0M |
| Cash Flow | |||||
| Operating Cash Flow | -120K | -519K | 125K | 2.01M | -3.69M |
| Capital Expenditure | 0.00 | 0.00 | 6.89K | 2.18M | 309K |
| Free Cash Flow | -120K | -519K | 118K | -171K | -4.00M |
| Ratios | |||||
| ROE | -19.0% | -20.7% | -3.5% | -2.7% | 0.5% |
| ROA | -18.9% | -20.3% | -3.0% | -2.2% | 0.4% |
| Net Profit Margin | - | - | -18.1% | -6.8% | 0.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
PharmaCorp Rx Inc. dividends
PharmaCorp Rx Inc. has not paid dividends in the last 4 fiscal years.
Who owns PharmaCorp Rx Inc.
- Insiders 8.31%
- Institutions 11.22%
- Public & others 80.47%
- Shares outstanding 197M
- Free float 159M
PharmaCorp Rx Inc. company profile
- Company name
- PharmaCorp Rx Inc.
- Ticker
- PCRX.V
- Exchange
- TSX Venture Exchange
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Employees
- 5
- Fiscal year end
- December
- Address
- 303 Wellman Lane, Saskatoon, SK, Canada, S7T 0J1
- Website
- pharmacorprx.ca
About PharmaCorp Rx Inc.
PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. The company offers prescription services; front-of-store retail, such as convenience goods, over-the-counter medications, health products, and wellness items; custom compounding; specialized consultations; and lifestyle programs. PharmaCorp Rx Inc. was incorporated in 2021 and is headquartered in Saskatoon, Canada.
PharmaCorp Rx Inc. management
6- Mr. Alan A. SimpsonExecutive Chairperson · born 1958
- Mr. Grady BrownCEO & Director
- Mr. Paul DalePresident & COO
- Mr. Calvin LeRouxStrategic Advisor to CEO
- Mr. Andrew HodsonChief Financial Officer
- Ms. Kimberly CarrollCorporate Secretary